Becton, Dickinson and Company (BD) has introduced the BD Vacutainer Urine Complete Cup Kit, designed to enhance diagnostic capabilities. This launch coincides with share price volatility, as BD trades at approximately $182.49, reflecting a 19.2% drop from its estimated fair value. In a proactive financial move, the company also announced a tender offer for up to $2 billion in 3.794% Senior Notes due 2050, underlining its commitment to shareholder value despite market challenges.
“BD (Becton, Dickinson and Company) · is · a leading global medical technology company”
“Becton, Dickinson and Company · share price · $176.66 · February 26th”
“Becton, Dickinson and Company · trailing P/E · 35.03”
“Becton, Dickinson and Company · forward P/E · 12.82”
“Becton, Dickinson and Company · dividend · $4.20”
“Becton, Dickinson and Company · historically repetitive high dividend yield · 1.6% · $255 share price”
“Becton, Dickinson and Company · recent share price · $192 · 2.1% yield”
“Becton, Dickinson and Company · historically repetitive low dividend yield · 1.1% · $355 per share”
“Becton, Dickinson and Company · ROIC · 10%”
“Becton, Dickinson and Company · free cash flow yield · 4%”
“Becton, Dickinson and Company · P/EBV · 0.9”
“Becton, Dickinson and Company · economic EPS · $6.45 · exceeds reported GAAP EPS of $5.81”